Back to Results
First PageMeta Content



Visterra Acquires Exclusive Patent License for Monoclonal Antibodies against Dengue Virus from MIT – Expands Company’s Therapeutic Pipeline for Infectious Diseases – Cambridge, MA – December 2, 2013 – Visterra,
Add to Reading List

Document Date: 2017-10-03 19:39:42


Open Document

File Size: 74,04 KB

Share Result on Facebook